Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Neuroone Medical Technologies (NMTC) Equity Ratio (2016 - 2025)

Neuroone Medical Technologies (NMTC) has disclosed Equity Ratio for 14 consecutive years, with 0.75 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Equity Ratio rose 65.13% year-over-year to 0.75, compared with a TTM value of 0.75 through Dec 2025, up 65.13%, and an annual FY2025 reading of 0.66, up 328.37% over the prior year.
  • Equity Ratio was 0.75 for Q4 2025 at Neuroone Medical Technologies, up from 0.66 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.93 in Q1 2022 and bottomed at 0.15 in Q3 2024.
  • Average Equity Ratio over 5 years is 0.72, with a median of 0.76 recorded in 2023.
  • The sharpest move saw Equity Ratio soared 421.53% in 2021, then plummeted 80.17% in 2024.
  • Year by year, Equity Ratio stood at 0.93 in 2021, then decreased by 8.85% to 0.85 in 2022, then fell by 10.3% to 0.76 in 2023, then tumbled by 40.44% to 0.45 in 2024, then soared by 65.13% to 0.75 in 2025.
  • Business Quant data shows Equity Ratio for NMTC at 0.75 in Q4 2025, 0.66 in Q3 2025, and 0.76 in Q2 2025.